clopidogrel has been researched along with insulin glargine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hasford, J; Lehmacher, W | 1 |
Ravid, M | 1 |
2 other study(ies) available for clopidogrel and insulin glargine
Article | Year |
---|---|
Benefit assessment in Germany.
Topics: Aspirin; Cardiovascular Diseases; Clopidogrel; Comparative Effectiveness Research; Germany; Government Agencies; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Long-Acting; National Health Programs; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine | 2010 |
Carcinophobia in clinical research.
Topics: Angiotensin Receptor Antagonists; Animals; Biomedical Research; Causality; Clopidogrel; Cyclooxygenase 2 Inhibitors; Humans; Incidence; Insulin Glargine; Insulin, Long-Acting; Neoplasms; Rosiglitazone; Thiazolidinediones; Ticlopidine | 2012 |